NFL is spending a lot of time in Florida now!
Avatar

t zyakaira "zyaada"

Vcard Download vCard   what is this?
Rss_icon

Recent Activity


Filter by:
All
  • Increasing Your Sales with No Out of Pocket (REW, rated BUY)  

    Doing this can aion kina be a real challenge and at times, really frustrating. So, I like to look at this process like playing a strategic board game. It takes some real “think out of the box” along with some good team players and some creative ideas, all mixed together aion leveling to reach the end of the game and win the prize as inexpensively as possible. Having weathered 3 economic slumps, I found a very key aion gold and free way to immediately increase sales without spending a dime.

    While every aion power leveling sale can be broken down into any number of pieces, there are really only two essential parts that encompass the sale from start to finish. The first is the business part, which would be all aspects of making the wow cd key sale; marketing, inventory, point of sale system, etc. Then there’s the human part. The interaction between your staff and the customers, how the customers cheap aion gold are greeted, helped, etc. The human part is the finesse or essence, if you will, of the harder business side of retail.

    As I’m sure you’ aion kinah ve seen, some customers want a lot of interaction from the sales person, showing them where things are in the store, telling them warhammer gold about current sales going on, etc. There are some who don’t want to be bothered by anyone at all. They want to be completely left alone, find what they aoc gold are looking for, pay and leave. Having a good staff, who can see which customers need a little hand holding and which do not, can make the shopping experience lotro gold more enjoyable for the customer and the staff as well. Proper care of how a customer wants to be treated will be a key reason to come back to your store. Customers remember that kind of eve isk thing.

    So when we talk about improving the shopping experience, thus improving sales, we need to think about building customer loyalty, not just the cataclysm power leveling customer service end of things. ffxiv gil I can’t stress enough how important customer loyalty is for staying power in the retail business. Here’s an interesting story. There’s a corner coffee shop I have been going to for about four years now. The cheap ffxiv gil coffee is pretty good and it’s marginally priced, but I keep going back because the owner and staff know who I am, they always smile when talking to me, they engage in conversation during the transaction aion cd key and seem to be genuinely interested in how I’m doing when I come in. They have my customer loyalty because the customer interaction is real, I’m not just another aion account Joe coming in for a cup of Joe! They care.

    Your staff should wow power leveling be responsible for having good manners with the customers, smiling at them, engaging in conversation, treating the customer with respect and ensuring they’ve actually helped the customer find what they cheapest wow gold need. Your role, as the owner or manager is to spot the right staff to be out interacting with the customers and the ones who are better placed in final fantasy xiv gold lower customer traffic zones. This is the part that is like playing a board game.

    Using strategy ffxiv cd key and capitalizing on the strengths and weaknesses of your team to better offset loss of potential sales, will give you an immediate return on investment. If you have an employee who is very social and enjoys talking to people, put aion kina that person on your front lines to greet new customers and help those customers find what they’re looking for. If you have another person who shows wow cd key leadership type initiative.

    Stephanie Aion crafting leveling tips Shalofsky is the founder Aion crafting leveling tips of The Organizing Zone Aion crafting leveling tips and a Professional Organizer Aion crafting leveling tips located in New York City. Aion crafting leveling tips She specializes in office WoW Ruby Sanctum organizing and Wrath of the Lich King works with both small Star Trek Online Mega Update   companies and Star Wars: The Old Republic E3 Recap and Opinion individuals with home EVE Live Event offices.

    <o:p>    </o:p>

    <o:p>   </o:p>

    cheap aion kinah

    cheap aion kinah

    cheap aion kinah

    cheap aion kinah

    cheap aion kinah

  • Javelin Pharma, Spire: Volume Movers (SPIR, rated BUY) http://suprastock.blogspot.com/2010/06/javelin-pharma-spire-v... http://suprastock.blogspot.com/ Spire (SPIR) jumped by 22 cents, or 6%, to $3.89 in Monday's after-market session after the solar equipment maker said it has been selected by the Department of Energy as the recipient of a Small Business Innovation Research grant to develop a light emitting diode (LED) based solar simulator. The 50-day average daily volume for Spire is 32,900, according to the Nasdaq.
  • VIVUS Inc. (VVUS) is a BUY As a primary care MD who spent many years working with patients to reduce health risk factors and prevent and/or reverse diseases (eg diabetes) by nutritional choices, exercise and weight loss I view Qnexa as a wonderful new tool to help. Obviously it needs to be prescribed carefully and patients must be closely monitored for side effects, should any develop. But this is a powerful tool and we need  powerful tools.   Both phentermine and tobrimate have been prescribed for a number of years. They are not unknown entities. Putting them together in low doses in slow release formulations appears to be a win win situation. Of course the FDA has a responsibility to protect the public from dangerous medications or drug candidates. It also has a responsibility to not delay the availability of candidates which have been screened according to established protocols and pass muster.  I would/will prescribe Qnexa when available,  if I am in practice, and expect it to relieve a great deal of human suffering. I am long on VVUS and OREX (whose drug candidates I also expect to be very helpful). The goal is not lifelong medication, but rather to help patients to progress with weight loss to a point where they have hope again and renewed motivation to devolop the disciplines necessary for health, and where (for example) they can exercise safely and without injuring themselves.
  • Top 10 Best-Rated Marine Transportation Stocks: DSX, DRYS, GNK, NM, SB, SSW, HOS, KEX, EGLE, CAP (Jun 27, 2010) (SB, rated BUY) http://suprastock.blogspot.com/2010/06/top-10-best-rated-mari... http://suprastock.blogspot.com Safe Bulkers, Inc. (NYSE:SB) is the 5th best-rated stock in this segment of the market. It is rated positively by 7 brokerage analysts. It is covered by 9 brokerage analysts.
  • EXPE-Top 10 Leisure Services Stocks with Highest Upside: CKEC, UTA, OWW, TZOO, FUN, EXPE, STNR, CHDN, CNK, PCLN (Jun 26, 2010) (EXPE, rated BUY) Expedia, Inc. (NASDAQ:EXPE) has the 6th highest upside potential in this segment of the market. Its upside is 51.4%. Its consensus target price is $29.61 based on the average of all estimates. http://suprastock.blogspot.com/2010/06/top-10-leisure-service... http://suprastock.blogspot.com/
  • Tellabs, Inc. - Talking to the Hand (TLAB, rated BUY) The world has become instantaneous.

    At any time of the day or night, on any day of any week during any month, companies have developed technology that allows any person anywhere in the world, to communicate with any other person, anywhere in the world.

    Consider that for a minute.

    How many of you have seen the live feeds coming from the Deepwater Horizon disaster in the Gulf of Mexico? We just took a look and there is approximately 40 seconds of delay between our computer and the camera taking the pictures which is located 5000 feet below the surface of the ocean. To us, that is just incredible.

    A couple of days ago, we came across an article about Tellabs, Inc. (Nasdaq: TLAB ), a company we had not thought about since the dot com bubble of the late 1990s.

    Curious, we looked up the price of the stock and were a bit surprised to it trading below $7.00. Granted, we have been out of the broadband loop for a good while, and during that time much has changed with the world economy, but below $7.00! Could that be right?

    Here we thought is one of the reasons, that we were able to watch a live video feed originating from the bottom of the ocean, and the reason was selling for less than $7.00. Could there be something wrong with this picture?

    Basis  
    Financial information related to Tellabs, Inc., contained in this report, is based on the company's most recent SEC Form 10-K filing , for year ending December 31, 2009, as filed with the Securities and Exchange Commission on March 01, 2010.  

    What They Do  
    Tellabs, Inc., is engaged in the design and marketing of equipment and services to communications services providers worldwide. The company’s products and services enable its customers to deliver wireline and wireless voice, data and video services to business and residential customers.

    The company sells its products domestically and internationally through its field sales force and distributors/partners. The company’s customers are primarily communication services providers, including local exchange carriers (LECs), global wireline and wireless service providers, multiple system operators (MSOs) and competitive service providers (CSPs). Its customer base also includes distributors, original equipment manufacturers (OEMs), system integrators and government agencies.

    The company was incorporated in 1975 as an Illinois corporation. In 1992, shareholders approved the formation of a holding company structure. Under that new structure the shareholders of Tellabs, Inc., an Illinois corporation, became the shareholders of a new holding company, Tellabs, Inc., a Delaware corporation.

    In December 2009, the company acquired WiChorus, Inc. (WiChorus), a supplier of infrastructure products for the mobile Internet. This acquisition will enable the company to quickly enter a large and fast growing market with a purpose-built 4G, LTE, and WiMax mobile-network solution that can be used in today’s 3G networks and complements the compan's IP mobile backhaul portfolio.

    In November 2004, the company acquired Advanced Fibre Communications, Inc. (AFC) of Petaluma, California, a supplier in North America of “last-mile access” products, over which are delivered residential voice, data and video services.

    In addition, in December 2004, the company acquired Vinci Systems, Inc. (Vinci), a privately held developer of customer-premises equipment used for fiber access. This acquisition accelerated the company's ability to deliver cost-reduced and feature-enhanced components.

    While the company retains its residential access business, in 2008, the company shifted its focus to more profitable opportunities in the mobile, optical, and business markets.  

    Short-Term Investment
    To us, it appears that the stock price may be at a bottom. The MACD is at its lowest point in over a year, and the Stochastic trend is now reflecting the stock's Oversold position. Barring an foreseen event, this would be the perfect point to take a position in the stock.

    With a recent close of $6.37 and First Resistance at $6.97, a 9% increase from a recent close, the upside appears extremely limited. Couple that with First Support at $4.96, a 22% decline from a recent close, and it almost appears that shorting the stock would be the order of the day.

    But it is important that short-term investors keep their eye on the ball here, and realize that Short-Term means a trading period based on a 13 day moving average, not a 50 day moving average or a 52 week high or low.

    Long-Term (5 Year Hold) Investment
    We reviewed the company's FY09 financials which seemed to us, quite solid, given the upheavals of the world economies. The company's Current Ratio, a Quick Ratio, and Cash Ratio, were all what we consider investment quality.

    In addition, the company has kept its Debt at near zero, finishing FY09 with total Debt of $0.02 per share, and at the same time, managed to turn its Inventory over almost 6.5 times during the year. Both of these things are, to us, outstanding achievements considering yet again the economies of the world.

    Yet all is not perfect. Over the past several years the company has acquired several companies. The results of these acquisitions, at least to us, do not seem to have improved the company's bottom line. They have however, managed to increase the company's Intangibles and Goodwill to a little more than 12.5% of Total Assets.

    This may not be a big deal to many investors, but for us it is of some concern, since we tend examine the balance between risk and reward when considering a company for investment.

    One other item of note centers around management, and is something we see often. The company's Accounts Receivable are outstanding an average of 99 days, while the company's Accounts Payables are outstanding an average of 32 days.

    What irritates us about this sort of situation is why management would allow the company to make a 60+ day interest free loan to its customers? Management needs to get a grip and realize they are in the electronics business and not the electronic banking business.  

    Valuations  
    Based on our preliminary review of the company's FY09 financial information, we believe a Reasonable Value Estimate for the company, assuming a 5 year hold, is in the $12 to $15 range.

    Considering our discussion regarding the stock as a short-term investment, we think starting a position at this time may be a wise move. Certainly we would not take a full position, which to us is between 2.5% and 3%, but would instead take a 1% to 1.5% position at current levels, adding to our position on pricing pullbacks and economic uncertainty.  

    Final Thoughts  
    The world continues to change, to evolve, perhaps according to some strategic plan put in place eons ago, perhaps according the wants of the people that inhabit it. Regardless of the reasons why, the demand for information, for entertainment, for communication, continue to grow.

    Recent changes in mobile technology have created the latest craze, 4G Technology , which is supposed to deliver greater content rich communications, something we admit, is completely lost on us.

    And while we personally may not be interested in watching an Orangutan drive a submarine through a traffic light in Manhattan, or spend 24 hours a day watching oil spew from a pipe at the bottom of the sea, we realize we are in the minority with our thinking.

    So line up America , and please continue to spend your money on glitter and gadgets, as we appreciate your contribution to our retirement efforts.  

    Wax  

    Worksheet  
    To download the Tellabs, Inc. Raw Vale worksheet, please click here .
  • LUMBER VS. S&P 500 : WHO WINS? WINNER TAKES IT ALL (CUT, rated SELL) I want to remind all my SA friends that right now I am short Dow futures since 11,000 and this is my biggest position. I make 4% each time Dow Jones goes down 1% and lose 4% each time DJIA goes up 1%. If you want to follow my strategy but still have most of your assets in stocks and don't have extra cash, then you can sell 50% of your equities and with raised cash buy either ( SDS ) ( DXD ) ( TWM ) ( QID ) this way all your equity will turn to 100% market neutral, because 50% in stocks and 50% in X2 short index ETF's will make your total performance almost neutral. Let's say DJIA will go down 50% and ( DXD ) then will go up 100%. If you have $100,000 trading account and $50,000 you keep in stocks the rest $50,000 in ( DXD ), your ( DXD ) in this case will raise your account to $100,000 and even if stocks will go down by then 50% as well, your final equity will be $125,000. This is almost market neutral (25% return is not considered big to me in a trending market with short leveraged position in Dow Jones index) and maybe it can be called a winning streak, considering most investors by then will lose 50% from today and 70-80% from 2007 DJIA top.
    This way you will survive the crash and make 25% with no risk to your stocks, by then I will make 200% (can advise everybody how to do it the same but you need a futures account for this).

    Now I want to explain what Lumber price action and cycle has to do directly with your stocks and why it's important to look at it and think how to use it in your favor.
    This indicator I have developed myself and opposite to all other TA analysis, this indicator is not based on market history, it precedes it and so it can be called forward analysis. As you know that all TA indicators are only based on price history from where they show how future might look like, that's why I never use it because future to me is more important than the past. Nobody knows the future (so do I) but I will try to show you that it's possible to look into it when we look into Lumber market and will use it as forward indicator for S&P 500 price action.
    All of you know what the stock market is, now let's take a look into Lumber pit.

    I will explain it so everybody can understand what LB is, for example if the last closing price of LB September 2010 future is $190 so when the full price of a contract is $20,900 or you must multiply the last price by $110 (value of one futures unit).
    Now let's see how big the futures market is (it's the smallest commodity in the world in volume of contracts traded and so money volume), the 5-day average volume for Lumber futures September is 600 contracts, in money in equals 600X$190 average priceX$110=$12,540,000 or this is how much Lumber $ value is traded for a September delivery.
    Now I compare it with the volume for S&P 500 E-mini futures for September as well.
    2,340,000 (average 5-day volume)X1070(average price)X$50(value of one futures unit)=$125,190,000,000 this is full $ value of trading that happens every day in S&P 500 E-mini futures for September expiration,
    And this is only one index future, there is also Nasdaq, Dow, Russell futures both big and mini sizes that trade the same every day, so you can imagine the size of it.
    Now back to S&P 500 and Lumber markets.
    E-mini S&P 500 $125B ($125 billion USD) daily volume
    Lumber $12.5M ($12.5 million USD) daily volume
    Lumber is 10,000 times smaller in volume than E-mini S&P 500 futures !!!
    I think if would compare Lumber to all index futures then it would be about 100,000 smaller in volume at least and if we add stock trading volume then this will be already millions time smaller and this is what had to be proven - Lumber is the smallest commodity in money volume in futures market worldwide.

    And that's why my Lumber indicator is more important than anything else, Lumber is a real market with the smallest leverage used to trade it because most Lumber traders are either producers/buyers who seek to lock in prices. There is not a single hedge fund who is focusing on Lumber futures trading and that's why Lumber is a pure supply/demand commodity free of manipulations, a commodity that I use as a market timing indicator for many years, because Lumber demand and price says about the health of the US economy, Lumber is used in every new house built , office building, house remodeling and when economy is growing so does demand for Lumber and price. Everybody spends money on his/her house and Lumber is a major housing commodity, right now it's price shows that economy is in deep depression because adjusted for inflation Lumber price is 70% below the price it was in the 1970's.

    Also interesting to note that Lumber moves first and only later market follows, because economic forecasts look at a big, complicated picture first to see the state of the economy, while Lumber is moving immediately when people start to buy wood products for their houses, when people have more money they spend right away on a house and when they don't have they simply don't spend and if people don't spend money on housing, economy is dead. When economy is dead stocks can't go up, they can only go down and my Lumber indicator shows that market will crash in the short time no matter what they say.


    The chart above shows that 25 years ago and before as well, Lumber and S&P500 were worth the same and in 1995 this correlation broke and current stock bubble began. One day S&P 500 will be 200 points only while Lumber will be at 1500 just as S&P 500 was at the top. You can trust me on this, I know few things.


    The chart above shows % correlation between S&P 500 and Lumber, it was Lumber that started stock rally in 2005 and Lumber finished it in 2008 then started it in 2009 again only to finish it now again. Using my Lumber forward indicator will show that the market will go down minimum 50% from here.


    Lumber chart from 1970's till present.



    Link: http://www.cmegroup.com/trading/commodities/files/AC-243_RanL...

    http://www.usdebtclock.org/
  • ECO ANIMAL HEALTH GROUP PLC : THE BEAUTIFUL WORLD OF THE ANIMALS, KEEP IT HEALTHY (AHII, rated SELL) I want to start this post with a question: Who is the biggest generic drug maker for the animal world? Your answer (more likely a question) most likely will be: Does such thing exist?  Now I want to ask you another question: What are the best known generic drug companies in the world? Your answer very likely will be: Novartis, Teva (Ratiopharm), Sanofi-Aventis, Mylan, Apotex, Watson, Dr. Reddy's, KV, Momenta, Pfizer, Stada, Bayer if you are investor in biotechnology sector then you know at least 3 companies from the list.
    But the fact is that generic drug company for the animals exist and their name is

    ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Our products for these growth markets promote well-being in animals. We are dedicated to the research and development of both new products and innovative, differentiated generics. The Company’s subsidiaries include Eco Animal Health Limited, Eco Animal Health (Europe) Limited, Eco Group Limited, Eco Animal Health Southern Africa (Pty) Limited, Petlove Limited, Zhejiang Eco Biok Animal Health Products Limited and Eco Animal Health do Brasil Comercio de Produtos Veterinarios Ltda. Our subsidiaries are engaged in manufacture of animal drugs. On October 1, 2009, the Company disposed of its interest in Interpet LLC. 

    Proprietary patented drugs
    Aivlosin® - macrolide antibiotic for treatment of respiratory & enteric diseases in pigs and poultry.

    Generic drugs
    Ecomectin®, Ecoheart, Ecotraz & Ecomintic (endectocides & other antiparasitics) for treatment & prevention of parasites in cattle, sheep, pigs, horses and dogs.
    Chlortet & Oxytet for treatment of bacterial infections in pigs, poultry & cattle.

    So now, after you know such company does exist let's look more deep into the world of generic pharmaceuticals and valuations for ( EAH ) stock in particular.
    Why generic pharmaceutical companies were so successful in the last two decades? It is only because the economies of scale for a global healthcare market
    and the price generic drug companies offered to the market - dumping price.
    Governments embraced and still embrace generic drugs because it cost so little compared to other available drugs. But now this market is at the peak, not because there is no demand, because there is a real competition right now. Every major pharma company can enter this market, these increasing risk for previous generic makers, cutting margins and starting price wars. After patent expires on a drug, everybody can make such generic version of the same drug and call it as they wish. What was so good about it (generic companies) even few years ago, now it's the opposite. Their exclusivity and monopoly status ended, that's why all stocks in this industry can't outperform a stock market as easy as before or outperform a pharmaceutical sector. The story is over for them and later I will describe what connection Teva stock going down has to do with success of ECO Animal Health investing. Now the numbers:
    WTFact
    Market Cap GBP 64,000,000 ($96,000,000) now compare it with ( TEVA ) market cap $47,000,000,000
    No, I am not comparing humans to animals (animals are better of course) or Teva market with animal health market, what I want to show is that valuation for ( EAH ) is very, very low compared to it's future potential. For example Teva only 10 years ago was worth 90% less than today or less than $5,000,000,000 and 20 years ago it was a penny stock, same as ( EAH ) today. Look at ( TEVA ) max. chart.
    Shares Outstanding 47,000,000
    Revenues GBP 20,000,000
    Price/Sales 3
    EPS GBP 0.01
    Dividend Yield 5.3%
    Cash GBP 4,000,000
    LT Debt 0
    Current Assets GBP 55,000,000
    Current Liabilities GPB 6,500,000
    Must add that assets were growing every year over past 10 years, not a single year of decline in assets. The only major shareholder that I know is Schroders plc who own 22% of the equity. A WIN-WIN




    Risk free trade that can faciliate even a very big trader, ex. buy $10,000 ( EAH ) sell short $10,000-$20,000 ( TEVA )
    This is a bet on time working for you rather than a stock bet, Teva will go down the slope no matter what while ECO Animal Health Group Plc will likely go up over the same time. If you sell short 2 (money amount) units of Teva for every long unit in EAH, you decrease your risk to nothing. Again, this is a long term bet because a market crash will wipe all the stocks in the beginning but long term EAH will do much better than Teva for sure. The below chart will look the same after decade only in EAH favor.


    Link: http://www.ecoanimalhealthgroupplc.com/

    http://www.ecoanimalhealth.com/

    http://www.aivlosin.com/aivlosin/

    EAH is listed on AIM in UK and trades is GBP:
    http://www.londonstockexchange.com/exchange/prices-and-news/s...

    P.S. I would like to remind that we need healthy animals more than animals need us, place a pig or a chicken in the wild and they will likely survive while human left in the wild will likely die faster than the animal. Healthy animal means healthy food to our children and that is another reason this is ( EAH ) a big business to make animals stay healthy. If they die, we die. The diseases in animals are growing at alarming rate from year to year and this is very good for EAH investors. I eat only bio and organic food and this is what I advise to you first, only then think about buying EAH and selling Teva short. In a healthy body, healthy spirit and clear mind.
  • Trading FDA, Clinical Trial Binary Events: Why Amarin (NASDAQ:AMRN) is My Top Buy (AMRN, rated BUY) Amarin Corp. (NASDAQ:AMRN) is developing AMR101 (Ethyl-EPA) as a prescription-grade omega-3 fatty acid that has been marketed in Japan for over 10 years as EPADEL by Mochida Pharma. Ethyl-EPA is differentiated from Glaxo's (NYSE:GSK) $1 billion dollar product LOVAZA (omega-3-acid ethyl esters) in the following key areas:

    <font> - no fishy smell / taste or GI side effects such as burping = better patient compliance since these are both taken every day </font>

    <font> - lacks Ethyl-DHA omega-3 fatty acid component, which can raise bad cholesterol (LDL) levels </font>

    <font> - potential to address a much larger patient population including those with triglyceride levels of 200-500 mg/dL vs. LOVAZA, which is indicated for patients with triglyceride levels greater than 500 mg/dL </font>

    <font> Amarin is fully funded through a potential NDA filing with ongoing partnership discussions. My current estimate is for patient enrollment to conclude by late 2010 to early 2011 (ahead of the most recent company guidance) with results expected by mid-2011 under this scenario since both studies have 12-week treatment periods. It should also be noted that both studies are being conducted under Special Protocol Assessments (SPA) with the FDA without the need for Phase 2 studies, supported by over 10 years of use in Japan and previous studies conducted by Amarin for a variety of neurological conditions. </font>

    <font> ANCHOR study: ClinicalTrials.gov ID NCT01047501 was last updated on 5/3/10 and is currently recruiting participants: "Evaluation of the Effect of Two Doses of AMR101 (Ethyl Icosapentate) on Fasting Serum Triglyceride Levels in Patients With Persistent High Triglyceride Levels (≥ 200 mg/dL and < 500 mg/dL) Despite Statin Therapy." </font>

    <font> MARINE study: ClinicalTrials.gov ID NCT01047683 was last updated on 6/9/10 and this study is no longer recruiting patients, which provides a strong hint that enrollment is likely to be completed soon and well ahead of the Company's previous guidance. The primary objective is to determine the efficacy of AMR101 (ethyl icosapentate) compared to placebo in lowering fasting triglyceride levels in patients with very high fasting triglyceride levels ≥ 500 and ≤ 2000 mg/dL. </font>

    <font> Looking at the financials, Amarin is fully funded through a potential NDA filing and ended 1Q10 with $44 million in cash and no debt with approximately 99 million shares of common stock outstanding. On a fully diluted basis, Amarin has about 148 million shares of common stock, which includes 7.8 million options outstanding with an average exercise price of $2.71 and 41.2 million warrants outstanding at an average exercise price of $1.75. </font>

    <font> Amarin is currently the largest holding in my Ameritrade account because of the following factors: </font>

    <font> - an under the radar opportunity with little research analyst coverage and largely unknown by Wall Street </font>

    <font> - targeting an enormous market opportunity that encompasses cardiovascular disease and the evolving recognition of the need to treat triglycerides, which has the potential to become a multi-billion market opportunity similar in scope and size to statin drugs such as the world's top selling drug Lipitor that is about to face generic competition </font>

    <font> - many potential big pharma suitors, including obvious names such as Glaxo given the potential threat to their billion dollar drug LOVAZA, which is currently the only FDA-approved prescription omega-3 fatty acid product and Pfizer (NYSE:PFE) which will soon face generic competition for Lipitor and may look for another potential blockbuster drug in the area of cardiovascular disease </font>

    <font> - potential for a milestone-based partnership ahead of the pivotal results since Ethyl-EPA represents a relatively low-risk of clinical development since it has been used for over a decade in Japan and represents a purified version of the major component in LOVAZA </font>

    <font> - potential for the Company to complete patient enrollment and report results from the pivotal studies ahead of current guidance (please note the timeline has already been shortened by one year from the Company's original guidance of reporting Phase 3 results in 2012) </font>

    <font> Below is a screen capture image of the recently added features for subscribers, including real-time stock trade updates on the member forum and the wikinvest.com real money portfolio tracker on the subscriber home page. </font>

    <font> www.mikehavRx.com </font> <font> is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The actively managed HavRx Regulatory Catalyst Index update report is currently tracking 593 entries and 393 companies (including approximately 200 stocks trading under $5 per share and 51 private companies). Promo codes (50% discount) are available for college students, investment clubs, and subscribers to my previous FDA Calendar or similar services. </font>

    <font> Disclosure: Long AMRN </font>

Next page